These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 24699530)

  • 1. Integrative "omic" analysis for tamoxifen sensitivity through cell based models.
    Weng L; Ziliak D; Lacroix B; Geeleher P; Huang RS
    PLoS One; 2014; 9(4):e93420. PubMed ID: 24699530
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genome-wide discovery of genetic variants affecting tamoxifen sensitivity and their clinical and functional validation.
    Weng L; Ziliak D; Im HK; Gamazon ER; Philips S; Nguyen AT; Desta Z; Skaar TC; Flockhart DA; Huang RS;
    Ann Oncol; 2013 Jul; 24(7):1867-1873. PubMed ID: 23508821
    [TBL] [Abstract][Full Text] [Related]  

  • 3. let-7 microRNAs induce tamoxifen sensitivity by downregulation of estrogen receptor α signaling in breast cancer.
    Zhao Y; Deng C; Lu W; Xiao J; Ma D; Guo M; Recker RR; Gatalica Z; Wang Z; Xiao GG
    Mol Med; 2011; 17(11-12):1233-41. PubMed ID: 21826373
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A polymorphism in the TC21 promoter associates with an unfavorable tamoxifen treatment outcome in breast cancer.
    Rokavec M; Schroth W; Amaral SM; Fritz P; Antoniadou L; Glavac D; Simon W; Schwab M; Eichelbaum M; Brauch H
    Cancer Res; 2008 Dec; 68(23):9799-808. PubMed ID: 19047159
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Population differences in microRNA expression and biological implications.
    Huang RS; Gamazon ER; Ziliak D; Wen Y; Im HK; Zhang W; Wing C; Duan S; Bleibel WK; Cox NJ; Dolan ME
    RNA Biol; 2011; 8(4):692-701. PubMed ID: 21691150
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 4-Hydroxytamoxifen enhances sensitivity of estrogen receptor α-positive breast cancer to docetaxel in an estrogen and ZNF423 SNP-dependent fashion.
    Wang G; Qin S; Zayas J; Ingle JN; Liu M; Weinshilboum RM; Shen K; Wang L
    Breast Cancer Res Treat; 2019 Jun; 175(3):567-578. PubMed ID: 30937657
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Simulation with cells in vitro of tamoxifen treatment in premenopausal breast cancer patients with different CYP2D6 genotypes.
    Maximov PY; McDaniel RE; Fernandes DJ; Korostyshevskiy VR; Bhatta P; Mürdter TE; Flockhart DA; Jordan VC
    Br J Pharmacol; 2014 Dec; 171(24):5624-35. PubMed ID: 25073551
    [TBL] [Abstract][Full Text] [Related]  

  • 8. circRNA_0025202 Regulates Tamoxifen Sensitivity and Tumor Progression via Regulating the miR-182-5p/FOXO3a Axis in Breast Cancer.
    Sang Y; Chen B; Song X; Li Y; Liang Y; Han D; Zhang N; Zhang H; Liu Y; Chen T; Li C; Wang L; Zhao W; Yang Q
    Mol Ther; 2019 Sep; 27(9):1638-1652. PubMed ID: 31153828
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endoxifen (4-hydroxy-N-desmethyl-tamoxifen) has anti-estrogenic effects in breast cancer cells with potency similar to 4-hydroxy-tamoxifen.
    Lim YC; Desta Z; Flockhart DA; Skaar TC
    Cancer Chemother Pharmacol; 2005 May; 55(5):471-8. PubMed ID: 15685451
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SNPs near the cysteine proteinase cathepsin O gene (CTSO) determine tamoxifen sensitivity in ERα-positive breast cancer through regulation of BRCA1.
    Cairns J; Ingle JN; Wickerham LD; Weinshilboum R; Liu M; Wang L
    PLoS Genet; 2017 Oct; 13(10):e1007031. PubMed ID: 28968398
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacological relevance of endoxifen in a laboratory simulation of breast cancer in postmenopausal patients.
    Maximov PY; McDaniel RE; Fernandes DJ; Bhatta P; Korostyshevskiy VR; Curpan RF; Jordan VC
    J Natl Cancer Inst; 2014 Oct; 106(10):. PubMed ID: 25258390
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic impact of a single-nucleotide polymorphism near the CTSO gene in hormone receptor-positive breast cancer patients.
    Hato Y; Kondo N; Yoshimoto N; Endo Y; Asano T; Dong Y; Nishimoto M; Takahashi S; Fujii Y; Nakanishi R; Toyama T
    Int J Clin Oncol; 2016 Jun; 21(3):539-47. PubMed ID: 26482374
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MiRNA-27a sensitizes breast cancer cells to treatment with Selective Estrogen Receptor Modulators.
    Ljepoja B; García-Roman J; Sommer AK; Wagner E; Roidl A
    Breast; 2019 Feb; 43():31-38. PubMed ID: 30415143
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development and Characterization of Novel Endoxifen-Resistant Breast Cancer Cell Lines Highlight Numerous Differences from Tamoxifen-Resistant Models.
    Jones CJ; Subramaniam M; Emch MJ; Bruinsma ES; Ingle JN; Goetz MP; Hawse JR
    Mol Cancer Res; 2021 Jun; 19(6):1026-1039. PubMed ID: 33627502
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The anti-proliferative effect of suramin towards tamoxifen-sensitive and resistant human breast cancer cell lines in relation to expression of receptors for epidermal growth factor and insulin-like growth factor-I: growth stimulation in the presence of tamoxifen.
    Boylan M; van den Berg HW; Lynch M
    Ann Oncol; 1998 Feb; 9(2):205-11. PubMed ID: 9553667
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA-519a is a novel oncomir conferring tamoxifen resistance by targeting a network of tumour-suppressor genes in ER+ breast cancer.
    Ward A; Shukla K; Balwierz A; Soons Z; König R; Sahin O; Wiemann S
    J Pathol; 2014 Aug; 233(4):368-79. PubMed ID: 24752803
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of microRNA expression on cellular proliferation.
    Lenkala D; LaCroix B; Gamazon ER; Geeleher P; Im HK; Huang RS
    Hum Genet; 2014 Jul; 133(7):931-8. PubMed ID: 24609542
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A survey of microRNA single nucleotide polymorphisms identifies novel breast cancer susceptibility loci in a case-control, population-based study of African-American women.
    Bensen JT; Graff M; Young KL; Sethupathy P; Parker J; Pecot CV; Currin K; Haddad SA; Ruiz-Narváez EA; Haiman CA; Hong CC; Sucheston-Campbell LE; Zhu Q; Liu S; Yao S; Bandera EV; Rosenberg L; Lunetta KL; Ambrosone CB; Palmer JR; Troester MA; Olshan AF
    Breast Cancer Res; 2018 Jun; 20(1):45. PubMed ID: 29871690
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Downregulation of microRNA-27b-3p enhances tamoxifen resistance in breast cancer by increasing NR5A2 and CREB1 expression.
    Zhu J; Zou Z; Nie P; Kou X; Wu B; Wang S; Song Z; He J
    Cell Death Dis; 2016 Nov; 7(11):e2454. PubMed ID: 27809310
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Accuracy of genome-wide imputation of untyped markers and impacts on statistical power for association studies.
    Hao K; Chudin E; McElwee J; Schadt EE
    BMC Genet; 2009 Jun; 10():27. PubMed ID: 19531258
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.